Serotypes and genotypes of invasive Streptococcus pneumoniaebefore and after PCV10 implementation in southern Brazil

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Caierão, Juliana ^a   Hawkins, Paulina ^b   Sant'anna, Fernando Hayashi ^a   Da Cunha, Gabriela Rosa ^a   D'Azevedo, Pedro Alves ^a   McGee, Lesley ^c   Dias, Cícero ^a  

^a Porto Alegre Federal University of Health Sciences   (Brazil)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MEROPENEM; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; VANCOMYCIN; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENETIC ANALYSIS; GENOTYPE; HUMAN; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VACCINATION; ANTIBIOTIC RESISTANCE; FEMALE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE;

STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; BRAZIL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; GENOTYPE; HUMANS; MALE; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; SEROGROUP; STREPTOCOCCUS PNEUMONIAE;

EID: 84910027963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111129     Document Type: Article

References (55)

1. Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71-79.
2. Quadros CA (2009) From global to regional: The importance of pneumococcal disease in Latin America. Vaccine 27S: C29-C32.
3. Andrade AL, Oliveira R, Vieira MA, Minamisava R, Pessoa Jr V, et al. (2012) Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil. Vaccine 30:1901-1909.
4. Casado-Flores J, Rodrigo C, Aristegui J, Martinon JM, Fenoll A, et al. (2008) Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 27:1020-1022.
5. Ardanuy C, Tabau F, Pallares R, Calatayud L, Domínguez MA, et al. (2009) Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 48:57:64.
6. Centers for Disease Control and Prevention (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine-United States, 1997-2006. MMWR Morb Mortal Wkly Rep 58:1-4.
7. Rückinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, et al. (2009) Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 27:4136-4141.
8. Rodenburg G, de Greef S, Jansen AG, de Melker HE, Schouls LM, et al. (2010) Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis 16:816-823.
9. Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, et al. (2010) Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 28:2642-2647.
10. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201:32-41.
11. Vestrheim DF, Hoiby EA, Bergsaker MR, Ronning K, Aaberge IS, et al. (2010) Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine 28:2214-2221.
12. Bettinger JA, Scheifele DW, Kellner JD, Halperin SA, Vaudry W (2010) The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine 28:2130-2136.
13. Van der Linden M, Weiss S, Falkenhorst G, Siedler A, Imöhl M, von Kries R (2012) Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine 30:5880-5885.
14. Afonso ET, Minamisava R, Bierrenbach AL, Escalante JJC, Alencar AP, et al. (2013) Effect of 10-Valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis 19:589-597.
15. Weinberger DM, Malley R, Lipstich M (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet 378:1962-1973.
16. Miller E, Andrews NJ, Waight PA, Slack MP, George RC (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11:760-68.
17. PAHO (2013) Informe Regional de SIREVA II, 2012: Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasores.
18. Spellerberg B & Brandt C (2011) Streptococcus. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Manual of Clinical Microbiology, ed., American Society for Microbiology, Washington, DC 331-349.
19. CLSI (2013) Performance Standards for Antimicrobial Susceptibility testing. Twenty-third informational Supplement. M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
20. Widdowson CA, Klugman KP (1998) Emergence of the M phenotype of the erythromycin-resistant pneumococci in South Africa. Emerg Infect Dis 4:277-281.
21. Brueggemann AB, Coffman SL, Rhomberg P, Huyn H (2002) Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother 46:680-8.
22. Enright MC, Spratt G (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060.
23. Pimenta FC, Carvalho M da G, Gertz RE, Bastos-Rocha CGB, Oliveira LSC, et al. (2011) Serotype and genotype distriution of pneumococcal carriage isolates recovered from Brazilian children attending day-care centers. J Medical Microbiol 60:1455-1459.
24. Zemlicková H, Crisóstomo I, Brandileone MC, Camou T, Castañeda E, et al. (2005) Serotype and clonal types of penicillin-susceptible Streptococcus pneumoniae causing invasive disease in children in five Latin American countries. Microb Drug Resistance 11:195-204.
25. Barroso DE, Godoy D, Castañeiras TM, Tulenko MM, Rebelo MC, et al. (2012) β-lactam resistance, serotype distribution, and genotypes of meningitiscausing Streptococcus pneumoniae, Rio de Janeiro, Brazil. Pediatr Infect Dis J 31:30-36.
26. Domingues CM, Verani JR, Montenegro Renoiner El, de Cunto Brandileone MC, Flannery, et al. (2014) Effectiveness of tem-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med 2:464-471.
27. Muñoz-Almagro C, Ciruela P, Esteva C, Marco Francesc, Navarro M, et al. (2011) Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J Infect 63:151-162.
28. Pichon B, La Dhani SN, Slack MPE, Segonds-Pichon A, Andrews NJ, et al. (2013) Changes in the molecular epidemiology of Streptococcus pneumoniae causing meningitis following the introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microiol 51:820-827.
29. Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M (2010) Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infection in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 28:5167-5173.
30. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, et al. (2004) Temporal and geographic stability of the serogroup specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190:1203-1211.
31. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, et al. (2009) Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PloS Medicine 6:1-13.
32. Jansen AGSC, Rodenurg GR, van der Ende A, van Alphen L, Veenhoven RH, et al. (2009) Invasive pneumococcal disease among adults: association among serotypes, disease characteristics and outcome. Clin Infect Dis 49:e23-29.
33. Inverarity D, Lamb K, Diggle M, Roertson C, Greenhalgh D, et al. (2011) Death or survival from invasive pneumococcal disease in Scotland: associations with serogroup and multilocus sequence types. J Med Microbiol 60:793-802.
34. Rakov AV, Ubukata K, Robinson DA (2011) Population structure hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing. Infect Genet Evol 11:1929-1939.
35. Zulz T, Wenger JD, Rudolph K, Robinson A, Rakov AV, et al. (2013) Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska. J Clin Microbiol 51:1402-1407.
36. Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, et al. (2006) Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194:682-688.
37. Flasche S, van Hoek AJ, Sheasby E, Waight P, Andrews N, et al. (2011) Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PloS Medicine 8:e1001017.
38. Birtles A, McCarthy N, Sheppard CL, Rutter H, Guiver M, et al. (2005) Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J Clin Microbiol 43:2004-2008.
39. Lin CJ, Chen PY, Huang FL, Lee T, Chi CS, Lin CY (2006) Radiographic, clinical, and prognostic features of complicated and uncomplicated communityacquired lobar pneumonia in children. J Microiol Immunol Infect; 39:489-95.
40. Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, et al. (2007) Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis 196:936-944.
41. Inverarity D, Diggleb M, Ure R, Johnsonc P, Altstadtd P, et al. (2011) Molecular epidemiology and genetic diversity of pneumococcal carriage among children in Beni State, Bolivia. Trans R Soc Trop Med and Hyg 105:445-451.
42. Laval CB, de Andrade AL, Pimenta FC, de Andrade JG, de Oliveira RM, et al. (2006) Serotype of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines. Clin Microbiol Infect 12:50-55.
43. Neves FPG, Pinto TCA, Corrêa MA, Barreto RA, Moreira LSG, et al. (2013) Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine. BMC Infect Dis 13:318.
44. Lucarevschi BR, Baldacci ER, Bricks LF, Bertoli CJ, Teixeira LM (2003) Oropharyngeal carriage of Streptococcus pneumoniae by children attending day care centers in Taubate, SP: correlation betwwn serotypes and the conjugated heptavalent pneumococcal vaccine. J Pediatr 79:215-220.
45. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, et al. (2001) Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microiol 39:2565-2571.
46. Moore MR, Gertz RE, Woodury RL, Barkocy-Gallagher GA, Schaffner W, et al. (2008) Population snapshot of emergent Strpetococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 197:1016-1027.
47. Willems RJL, Hanage WP, Bessen DE, Feil EJ (2011) Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance. FEMS Microbiol Rev 35:872-900.
48. Hsieh YC, Lin TL, Chang KY, Huang YC, Chen CJ, et al. (2013) Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan 19F-14 (ST236). J Infect Dis 15:203-210.
49. Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, et al. (2009) Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother 64:507-510.
50. Shin J, Baek JY, Kim SH, Song JH, Ko KS (2011) Predominance of ST320 among Streptococcus pneumoniae serotype 19A isolates from 10 Asian countries. J Antimicrob Chemother 66:1001-1004.
51. Gene A, del Amo E, Iñigo M, Monsonis M, Pallares R, et al. (2013) Pneumococcal serotypes causing acute otitis media among children in Barcelona (1999-2011): emergence of the multirresistant clone ST320 of serotype 19A. Pediatr Infect Dis J 32:e128-133.
52. van der Linden M, Reinert RR, Kern WV, Imöhl M (2013) Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect Dis 13:70. doi: 10.1186/1471-2334-13-70.
53. Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, et al. (2003) Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Braz J Infect Dis 7:44-61.
54. Alvares JR, Mantese OC, Paula AD, Wolkers PC, Almeida VV, et al. (2011) Prevalence of pneumococcal serotypes and resistance to antimicrobial agents in patients with meningitis: tem-year analysis. Braz J Infect Dis 15:22-27.
55. Rossi F, Franco MR, Rodrigues HM, Andreazzi D (2012) Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin. J Brasi Pneumol 38:66-71.